The Canadian model shared with her Instagram followers that a fat-removing procedure from 2016 led to the development of paradoxical adipose hyperplasia, a rare and often unreported side effect of CoolSculpting in which fat cells respond by growing instead of shrinking.
Evangelista said PAH was the reason why she has “not been working while my peers’ careers have been thriving.” She said she has undergone corrective procedures but is still “permanently deformed.”
“PAH has not only destroyed my livelihood, it has sent me into a cycle of deep depression, profound sadness, and the lowest depths of self-loathing,” she wrote.
Evangelista said she has filed a lawsuit against Zeltiq, the company that invented CoolSculpting and is owned by global pharmaceutical giant Allergan.
Allergan did not respond to request for comment.
Providers are changing their business models to cater to the younger generation’s focus on prevention and Instagrammable fixes, as interest in cosmetic procedures rises.